Testing an MBI for Smoking Cessation and Alcohol Use Among Cancer Survivors

Recruiting now · Not applicable

Conditions studied: Smoking Cessation, Alcohol Use

In brief

This study will examine the efficacy of Mindfulness-Based Relapse Prevention for Smoking and Alcohol (MBRP-SA) compared to standard care among cancer survivors who smoke cigarettes and engage in at-risk alcohol use. Investigators will evaluate implementation outcomes through structured stakeholder interviews across medical centers, cancer-focused organizations, and community-based programs in Florida, and will conduct a cost-assessment and an incremental cost-effectiveness analysis of the two conditions.

Key facts

Study ID

NCT07447635

Run by

H. Lee Moffitt Cancer Center and Research Institute

People needed

600

Starts

2026-05-15

Expected to finish

2029-12-01

Last updated by the study team

2026-05-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• ≥18 years old
• History of a cancer diagnosis at any point in lifetime
• Smoked ≥1 cigarette/day in past month
• At least one binge drinking episode in past month or exceeds weekly drinking limits
• Motivated to quit smoking and modify alcohol use in next 30 days
• Valid home address in Florida
• English-speaking, reading, and writing ability

You may not qualify if…

• Pregnancy or lactation
• Active psychotic disorder
• History of severe alcohol withdrawal
• Current use of tobacco cessation medication or other treatments to quit smoking
• End-of-life or hospice care
• Household member already enrolled

Where it is running

• Moffitt Cancer Center — Tampa, Florida, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.